Vestmark Advisory Solutions Inc. Sells 4,383 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Vestmark Advisory Solutions Inc. lessened its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 6.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 61,954 shares of the medical device company’s stock after selling 4,383 shares during the quarter. Vestmark Advisory Solutions Inc.’s holdings in Cooper Companies were worth $5,695,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Victory Capital Management Inc. boosted its stake in Cooper Companies by 23.0% during the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after acquiring an additional 737,726 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Cooper Companies during the 4th quarter valued at $64,826,000. JPMorgan Chase & Co. raised its position in Cooper Companies by 13.2% in the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after acquiring an additional 573,908 shares during the period. Alecta Tjanstepension Omsesidigt bought a new position in Cooper Companies during the fourth quarter valued at $49,550,000. Finally, Swedbank AB lifted its holdings in Cooper Companies by 14.0% during the fourth quarter. Swedbank AB now owns 1,629,602 shares of the medical device company’s stock valued at $149,809,000 after purchasing an additional 200,000 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Shares of NASDAQ:COO opened at $91.33 on Thursday. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $18.23 billion, a price-to-earnings ratio of 46.84, a PEG ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 12 month low of $84.76 and a 12 month high of $112.38. The firm’s 50-day moving average is $92.56 and its 200 day moving average is $99.51.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business’s revenue was up 9.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.87 earnings per share. Research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on COO shares. Morgan Stanley decreased their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Wells Fargo & Company lifted their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Finally, Citigroup dropped their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies currently has a consensus rating of “Moderate Buy” and a consensus price target of $117.22.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.